JAGSNPHARM Jagsonpal Pharmaceuticals Ltd Earnings Reports Announcement 2023 - Earnings Report JAGSONPAL PHARMACEUTICALS LIMITED announces Q2 & H1 FY24 results with revenues at ₹57.8 crores and EBITDA margins at 21.7%..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Jagsonpal Pharmaceuticals Ltd